Structure-Activity Relationships and Drug Design
Drug Discovery: Overview
Quantitative Aspects of Drug-Receptor Interaction
Pharmacogenomics: Identification of New Drug Targets
Biopharmaceutical Factors Influencing Drug Product Design: Overview
In Vitro Drug Dissolution: Compendial Testing Models II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 8, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Gisbert Schneider1, Kimito Funatsu2, Yasushi Okuno3
1Swiss Federal Institute of Technology (ETH), Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, CH-, 8093, Zurich, Switzerland.
No abstract available in PubMed .
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025